Beta-Thalassemia Completed Phase 2 Trials for Deferoxamine (DB00746)

Also known as: Beta-thalassemia / Thalassemia beta / Beta thalassemia / Beta thalassaemia / Beta thalassemia major / Thalassaemia beta / Beta-thalassaemia

IndicationStatusPhase
DBCOND0027982 (Beta-Thalassemia)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00000595Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional HemochromatosisTreatment